Acute Myocardial Infarction study: CBCR
Official title BRIDGE Trial: Embedding Consumer-grade mHealth Technologies Into Cardiac Rehabilitation
ClinicalTrials.gov ID: NCT07741396
What this study is testing
- What it's testing
- The purpose of the BRIDGE study is to learn whether supplementing traditional center-based cardiac rehabilitation (CBCR) with a mobile health technology intervention can help patients monitor their health, stay engaged in healthy lifestyle behaviors, better manage cardiovascular risk factors, and improve overall health outcomes.
Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Adults aged 18 years or older.
- Enrolled in or referred to Phase II Center-based Cardiac Rehabilitation Program.
- Acute myocardial infarction
- Percutaneous coronary intervention
- Coronary artery bypass graft surgery
You likely can't join if
- Not enrolled in or not planning to participate in Phase II Center-based Cardiac Rehabilitation Program.
- Presence of a medical, cognitive, psychiatric, or physical condition that, in the opinion of the investigators or CR team, would preclude safe...
- Severe cognitive impairment or active psychiatric illness that would interfere with informed consent or study participation.
- Terminal illness or other serious medical condition that in the judgement of the treating clinician or investigator would likely preclude completion...
- Current hospice enrollment or residence in a long-term care facility that would preclude participation in the intervention or completion of study...
- Currently participating in another behavioral or digital health intervention trial that could confound study outcomes.
See the full eligibility criteria
- Adults aged 18 years or older.
- Enrolled in or referred to Phase II Center-based Cardiac Rehabilitation Program.
- Acute myocardial infarction
- Percutaneous coronary intervention
- Coronary artery bypass graft surgery
- Chronic heart failure with reduced ejection fraction
- Heart valve repair or replacement
- Stable angina
- Able to ambulate and participate in exercise testing and training as required by the CR program
- Ability to speak and read in English
- Willing and able to provide informed consent.
- Willing to use study-related devices/apps and complete study assessments.
- Not enrolled in or not planning to participate in Phase II Center-based Cardiac Rehabilitation Program.
- Presence of a medical, cognitive, psychiatric, or physical condition that, in the opinion of the investigators or CR team, would preclude safe participation in the study or adherence to study procedures.
- Severe cognitive impairment or active psychiatric illness that would interfere with informed consent or study participation.
- Terminal illness or other serious medical condition that in the judgement of the treating clinician or investigator would likely preclude completion of the study follow-up period. .
- Current hospice enrollment or residence in a long-term care facility that would preclude participation in the intervention or completion of study follow-up procedures.
- Currently participating in another behavioral or digital health intervention trial that could confound study outcomes.
- Inability or unwillingness to use the required mobile devices, applications, or monitoring equipment, if applicable.
The study team makes the final eligibility decision.
Where it is enrolling
- Chicago, Illinois, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Chicago, Illinois, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.